Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit frontier targets in RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) Inhibitors designed to suppress diverse oncogenic variants of RAS proteins, and RAS Companion Inhibitors for use in combination treatment strategies. As a new member of the Revolution Medicines team, you will join other outstanding Revolutionaries in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: Revolution Medicines is seeking a motivated summer intern to evaluate computational strategies for resolving tumor and tumor microenvironment (TME) states from bulk, single-cell, and spatial transcriptomic data in oncology. This project will focus on benchmarking deconvolution methods and assessing single-cell analysis best practices to determine the most biologically accurate and reproducible approaches for studying treatment response and resistance to targeted therapies, including RAS(ON) inhibitors.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Career Level
Intern